Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.
 BACK TO LIST

Laboratory Report

Patient
Name: Roberts, Carly
DOB: 10-DEC-1969 (Age: 56)
Gender: female
Address:
2 Price meadow
LE4 Mitchellborough (United Kingdom)
ID: 9384-259853-9 (ECI)
Report
Date: 08-NOV-2024
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
St Matthews Health & Community Centre
Malabar Road 62-66
LE1 4 Leicester (United Kingdom)
Specimen
Collected: 08-NOV-2024

Hematology

Test 08-NOV-2024 Reference Range Unit
Leukocytes [#/volume] in Blood by Automated count 4.1 4.0 - 11.0 10*3/uL
Erythrocytes [#/volume] in Blood by Automated count 4.9 4.2 - 5.4 10*6/uL
Hemoglobin [Mass/volume] in Blood 15.6 12 - 16 g/dL
Hematocrit [Volume Fraction] of Blood by Automated count 36.0 36 - 46 %
MCV [Entitic mean volume] in Red Blood Cells by Automated count 92.4 80 - 100 fL
MCH [Entitic mass] by Automated count 31.9 27 - 33 pg
MCHC [Entitic Mass/volume] in Red Blood Cells by Automated count 32.1 32 - 36 g/dL
Erythrocyte [DistWidth] in Blood by Automated count 14.5 11.5 - 14.5 %
Platelets [#/volume] in Blood by Automated count 300.6 150 - 450 10*3/uL

Chemistry

Test 08-NOV-2024 Reference Range Unit
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma 1450.5 H 0 - 450 pg/mL
Glucose [Mass/volume] in Serum or Plasma 86.3 65 - 99 mg/dL
Urea nitrogen [Mass/volume] in Serum or Plasma 15.7 7 - 20 mg/dL
Creatinine [Mass/volume] in Serum or Plasma 0.7 0.5 - 1.1 mg/dL
Calcium [Mass/volume] in Serum or Plasma 9.7 8.6 - 10.3 mg/dL
Sodium [Moles/volume] in Serum or Plasma 139.9 135 - 145 mmol/L
Potassium [Moles/volume] in Serum or Plasma 4.7 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Serum or Plasma 107.5 98 - 110 mmol/L
Carbon dioxide, total [Moles/volume] in Serum or Plasma 28.1 22 - 32 mmol/L
Protein [Mass/volume] in Serum or Plasma 6.4 L 6.6 - 8.3 g/dL
Albumin [Mass/volume] in Serum or Plasma 4.5 3.5 - 5.2 g/dL
Bilirubin.total [Mass/volume] in Serum or Plasma 0.5 0.1 - 1.2 mg/dL
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 40.9 32 - 91 U/L
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 12.3 7 - 56 U/L
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 19.1 10 - 40 U/L
Magnesium [Mass/volume] in Serum or Plasma 2.3 H 1.7 - 2.2 mg/dL
Cholesterol [Mass/volume] in Serum or Plasma 188.6 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 134.9 0 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 133.7 H 0 - 100 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 28.0 L 40 - 60 mg/dL
Hemoglobin A1c/Hemoglobin.total in Blood 5.5 4.0 - 5.6 %
Troponin I.cardiac [Mass/volume] in Serum or Plasma by High sensitivity method 0.0 0.0 - 19.9 pg/mL
Ferritin [Mass/volume] in Serum or Plasma 132.2 13 - 150 ug/L
Iron [Mass/volume] in Serum or Plasma 151.8 50 - 170 ug/dL
Iron binding capacity [Mass/volume] in Serum or Plasma 375.8 250 - 450 ug/dL
Iron saturation [Mass Fraction] in Serum or Plasma 31.8 15 - 50 %

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows markedly elevated NT-proBNP, suggesting possible heart failure or significant cardiac stress. Lipid profile reveals high LDL and low HDL cholesterol, increasing cardiovascular risk. Serum protein is slightly low, and magnesium is mildly elevated. Other parameters, including renal, liver, hematologic, and glycemic markers, are within normal limits. Clinical correlation and further cardiac evaluation are recommended.